Silbersher
Silbersher v. Allergan plc
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ZACHARY SILBERSHER, et al., Case No. 18-cv-03018-JCS Plaintiffs, ORDER GRANTING MOTION TO v. CERTIFY ORDER FOR IMMEDIATE APPEAL AND FOR STAY, VACATING ALLERGAN INC., et al., FEBRUARY 5, 2021 MOTION HEARING AND CONTINUING Defendants. FURTHER CASE MANAGEMENT CONFERENCE TO JUNE 4, 2021
Re: Dkt. No. 136
13 I. INTRODUCTION Plaintiff-Relator Zachary Silbersher (“Relator”) brings this action against two sets of defendants: 1) the Allergan Defendants (“Allergan”); and 2) the Adamas Defendants (“Adamas”). He asserts claims under the federal False Claims Act (“FCA”), 31 U.S.C. §§ 3729-3733, based on allegations that Adamas and Allergan misled the United States Patent Office (“PTO”) into issuing invalid patents protecting the drugs Namenda XR® and Namzaric®, thus…